KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Teladoc Health (TDOC) Net Margin (2016 - 2025)

Teladoc Health's Net Margin history spans 12 years, with the latest figure at 3.91% for Q4 2025.

  • For Q4 2025, Net Margin rose 364.0% year-over-year to 3.91%; the TTM value through Dec 2025 reached 7.92%, up 3105.0%, while the annual FY2025 figure was 7.92%, 3105.0% up from the prior year.
  • Net Margin for Q4 2025 was 3.91% at Teladoc Health, up from 7.91% in the prior quarter.
  • Across five years, Net Margin topped out at 1.98% in Q4 2021 and bottomed at 1180.6% in Q1 2022.
  • The 5-year median for Net Margin is 11.51% (2022), against an average of 131.2%.
  • The largest annual shift saw Net Margin tumbled -113660bps in 2022 before it skyrocketed 116960bps in 2023.
  • A 5-year view of Net Margin shows it stood at 1.98% in 2021, then plummeted by -30044bps to 597.46% in 2022, then soared by 99bps to 4.37% in 2023, then crashed by -73bps to 7.55% in 2024, then surged by 48bps to 3.91% in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Net Margin are 3.91% (Q4 2025), 7.91% (Q3 2025), and 5.16% (Q2 2025).